Dear Users,

The journal ratings for Impact Factor 2024 have been published.

https://jcr.clarivate.com

Bányai Emese

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2013-2026

2026

Enyedi, E. E., Szabó, A. Á., Pintér, T. B., Mányiné Siket, I., Pluhár, A., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Albumin-Bound Fatty Acids Modulate Endogenous Angiotensin-Converting Enzyme (ACE) Inhibition.
Biomedicines. 14 (1), 1-19, (article identifier: 103), 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)

Q1 Medicine (miscellaneous) (2025)

2025

Szabó, A. Á., Enyedi, E. E., Pintér, T. B., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Interference-Free Measurement of Urinary Angiotensin-Converting Enzyme (ACE) Activity: Diagnostic and Therapeutic Monitoring Implications.
Biomedicines. 13 (10), 1-17, (article identifier: 2528), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

2024

Szabó, A. Á., Enyedi, E. E., Altorjay, I., Hajnal, P., Pintér, T. B., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Get reliable laboratory findings: how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?.
Clin. Chem. Lab. Med. 62 (7), 1393-1401, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry (medical)

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

2020

Enyedi, A., Csongrádi, A., Altorjay, I., Beke, G. L., Váradi, C., Enyedi, E. E., Kiss, D. R., Bányai, E., Kalina, E., Kappelmayer, J., Tóth, A., Papp, Z., Takács, I., Fagyas, M.: Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis.
Clin. Chim. Acta. 500, 155-162, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Biochemistry (medical)

Q2 Clinical Biochemistry

Q2 Medicine (miscellaneous)

2018

Erdei, J. Z., Tóth, A., Balogh, E., Nyakundi, B. B., Bányai, E., Ryffel, B., Paragh, G., Cordero, M. D., Jeney, V.: Induction Of NLRP3 Inflammasome Activation By Heme In Human Endothelial Cells.
Oxidative Med. Cell. Longev. 2018, 1-14, (article identifier: 4310816), 2018.

doi DEA

Journal metrics:

Q2 Aging

Q1 Biochemistry

Q2 Cell Biology

Q1 Medicine (miscellaneous)

2017

Bányai, E., Fagyas, M.: Az ESC 2016. évi, a pitvarfibrilláció kezelésére vonatkozó ajánlása.
Rosegger Kft., Budapest, 56 p., 2017.

DEA

Bányai, E., Fagyas, M.: Az ESC/EACTS 2016. évi, a pitvarfibrilláció ellátására vonatkozó ajánlása.
Cardiol. Hung. 47, 1-87, 2017.

DEA

2016

Balogh, E., Tóth, A., Szilágyi-Tolnai, E., Bodó, T., Bányai, E., Szabó, D. J., Petrovski, G., Jeney, V.: Osteogenic differentiation of human lens epithelial cells might contribute to lens calcification.
Biochim. Biophys. Acta. Mol. Basis Dis. 1862 (9), 1724-1731, 2016.

doi DEA WoS Scopus

Journal metrics:

Q1 Molecular Biology

Q1 Molecular Medicine

Becs, G., Zarjou, A., Agarwal, A., Sikura, K. É., Becs, Á., Nyitrai, M., Balogh, E., Bányai, E., Eaton, J. W., Arosio, P., Poli, M., Jeney, V., Balla, J., Balla, G.: Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells.
J. Cell. Mol. Med. 20 (2), 217-230, 2016.

doi DEA

Journal metrics:

Q2 Cell Biology

Q1 Molecular Medicine

2014

10.

Fagyas, M., Úri, K., Mányiné Siket, I., Daragó, A., Boczán, J., Bányai, E., Édes, I., Papp, Z., Tóth, A.: New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
PLoS One. 9 (4), 1-29, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

11.

Fagyas, M., Úri, K., Mányiné Siket, I., Fülöp, G. Á., Csató, V., Daragó, A., Boczán, J., Bányai, E., Szentkirályi, I., Maros, T. M., Szerafin, T., Édes, I., Papp, Z., Tóth, A.: New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
PLoS One. 9 (4), 1-28, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

12.

Fagyas, M., Úri, K., Mányiné Siket, I., Daragó, A., Boczán, J., Bányai, E., Édes, I., Papp, Z., Tóth, A.: New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.
PLoS One. 9 (4), 1-29, 2014.

DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

13.

Bányai, E., Balogh, E., Fagyas, M., Arosio, P., Hendrik, Z., Király, G., Szemán-Nagy, G., Tánczos, B., Pócsi, I., Balla, G., Balla, J., Bánfalvi, G., Jeney, V.: Novel functional changes during podocyte differentiation: increase of oxidative resistance and H-ferritin expression.
Oxid. Med. Cell. Longev. 2014, 1-10, 2014.

doi DEA

Journal metrics:

Q2 Aging

Q2 Biochemistry

Q2 Cell Biology

Q1 Medicine (miscellaneous)

2013

14.

Potor, L., Bányai, E., Becs, G., Soares, M. P., Balla, G., Balla, J., Jeney, V.: Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin.
Oxid. Med. Cell. Longev. 2013, [1-13], 2013.

doi DEA

Journal metrics:

Q2 Aging

Q2 Biochemistry

Q3 Cell Biology

Q1 Medicine (miscellaneous)